# Clinical Trial Scheme of Xinnaoning Capsule

> **NCT03914131** · PHASE4 · UNKNOWN · sponsor: **Beijing Duheng for Drug Evaluation and Research Co., Ltd. (DDER)** · enrollment: 240 (estimated)

## Conditions studied

- Chronic Stable Angina Pectoris
- Qi Stagnation and Blood Stasis Syndrome

## Interventions

- **DRUG:** Xinnaoning Capsule
- **OTHER:** Xinnaoning Capsule Simulator

## Key facts

- **NCT ID:** NCT03914131
- **Lead sponsor:** Beijing Duheng for Drug Evaluation and Research Co., Ltd. (DDER)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-15
- **Primary completion:** 2019-12
- **Final completion:** 2020-04
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2019-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03914131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03914131, "Clinical Trial Scheme of Xinnaoning Capsule". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03914131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*